COVID-19: 'Real-world' analysis of coronavirus vaccine in Israel raises questions about UK strategy

3 年前

The first real-world analysis of the Pfizer/BioNTech coronavirus vaccine suggests it is matching its performance in clinical trials, but raises serious questions about the UK's decision to delay the second dose.